1. Wang J, et al. Peripheral serum metabolomic profiles inform central cognitive impairment. Sci Rep. Aug 20;10(1):14059. (2020).

2. Mahmoudian Dehkordi, S. et al. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome. Alzheimers Dement 15, 76-92, (2019).

3. Nho, K, et al. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 15, 232-244, (2019).

4. Zheng, X. et al. Hyocholic acid species as novel biomarkers for metabolic disorders. Nat Commun 12, 1487, (2021).

5. Wei M, et al. A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility. EBioMedicine. May;55:102766. (2020).

6. Zhao, L. et al. A panel of free fatty acid ratios to predict the development of metabolic abnormalities in healthy obese individuals. Sci Rep 6, 28418, (2016).

7. Ni, Y. et al. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals. EBioMedicine 2, 1513-1522, (2015).

8. Gu, Y. et al. Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects. J Proteome Res 12, 5801-5811, (2013).

9. Sang, C. et al. Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease. J Proteome Res 20, 2340-2351, (2021).

10. Xie, G. et al. Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection. BMC Med 18, 144, (2020).

11. Chen T, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics. Jul;10(7) (2011).

12. Yang J, et al. Potential metabolite markers of schizophrenia. Mol Psychiatry. Jan;18(1):67-78. (2013).

13. Xie, G. et al. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS. J Proteome Res 14, 850-859, (2015).